Epithalon
L-alanyl-L-glutamyl-L-aspartyl-glycine
Epithalon is a synthetic tetrapeptide consisting of four amino acids (Ala-Glu-Asp-Gly) developed by Khavinson and colleagues in Russia during the late 1980s. With a molecular weight of 390.35 g/mol, this compact peptide mimics a segment of the naturally occurring thymic peptide epithalamin extracted from pineal glands, making it a valuable tool for research into telomere elongation, pineal gland function, and cellular aging processes in controlled experimental settings.
Complete Research Database
Clinical Research Outcomes
Female, 55, Age-related Decline
“I feel like I've turned back the clock 10 years - energy levels are incredible.”
Clinical Outcome Measures
Cardiovascular & Metabolic Outcomes
Blood Pressure Reduction
Triglycerides
HDL Cholesterol
Waist Circumference
C-Reactive Protein
Sleep Apnea Events
Medical Disclaimer
Epithalon is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Long-term safety data in humans is extremely limited.